Procter & Gamble
PG Mega CapConsumer Defensive · Household & Personal Products
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Procter & Gamble en bref
Procter & Gamble (PG) is currently trading at 131,73 € with a market capitalization of 306,7 Md €. The trailing P/E ratio stands at 22.04x, with a forward P/E of 21.27x. The 52-week range spans from 120,10 € to 145,96 €; the current price is 9.7% below the yearly high. Year-over-year revenue growth stands at +7.4%. The net profit margin stands at 19.16%.
💰 Dividende
Procter & Gamble currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
23 analystes évaluent Procter & Gamble (PG) au consensus : Acheter. L'objectif de cours moyen est de 142,62 €, soit un potentiel de +8.27% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 126,54 € à 162,32 €.
Procter & Gamble : la thèse d'investissement en détail
Procter & Gamble (PG) operates in the Consumer Defensive — specifically Household & Personal Products — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
The combination of a 50.98% gross margin and 23.05% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Return on equity of 31.11% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard. Free cash flow is positive and net margins stand at 19.16%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.
Valorisation en contexte
At a PEG of 4.28, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.
Thèse d'investissement : forces et faiblesses
- Rentabilité élevée des capitaux propres (31.11% ROE)
- Marge brute élevée de 50.98% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- Free cash flow positif
Aucun signal d'alerte significatif dans les indicateurs actuels.
Aperçu technique
The price is in a transition zone relative to the moving averages — no clear signal.
Profil de risque
The data points to relatively defensive market behavior.
Trading Data
Related Stocks in the Same Sector
More Consommation de Base stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Procter & Gamble?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
